Charles Schwab Investment Management Inc. increased its position in Hyliion Holdings Corp. (NYSE:HYLN – Free Report) by 2.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,057,394 shares of the company’s stock after buying an additional 20,541 shares during the period. Charles Schwab Investment Management Inc. owned about 0.61% of Hyliion worth $2,622,000 as of its most recent SEC filing.
A number of other institutional investors have also modified their holdings of HYLN. Creative Planning acquired a new position in Hyliion during the third quarter worth approximately $29,000. AQR Capital Management LLC purchased a new stake in Hyliion during the second quarter worth approximately $40,000. Intech Investment Management LLC purchased a new stake in Hyliion during the third quarter worth approximately $77,000. The Manufacturers Life Insurance Company grew its stake in Hyliion by 20.7% during the second quarter. The Manufacturers Life Insurance Company now owns 58,072 shares of the company’s stock worth $94,000 after buying an additional 9,948 shares during the period. Finally, Price T Rowe Associates Inc. MD grew its stake in Hyliion by 9.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 104,086 shares of the company’s stock worth $184,000 after buying an additional 8,580 shares during the period. Institutional investors and hedge funds own 22.81% of the company’s stock.
Hyliion Stock Down 0.3 %
NYSE HYLN opened at $3.00 on Monday. The stock has a market capitalization of $521.19 million, a PE ratio of -8.11 and a beta of 2.03. The company has a 50 day moving average price of $2.84 and a two-hundred day moving average price of $2.23. Hyliion Holdings Corp. has a 12-month low of $0.62 and a 12-month high of $4.09.
Wall Street Analysts Forecast Growth
Read Our Latest Stock Report on Hyliion
Insider Activity
In related news, Director Jeffrey A. Craig purchased 50,000 shares of Hyliion stock in a transaction that occurred on Wednesday, November 20th. The shares were acquired at an average price of $2.95 per share, for a total transaction of $147,500.00. Following the transaction, the director now directly owns 282,060 shares in the company, valued at approximately $832,077. This represents a 21.55 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Vincent T. Cubbage sold 65,000 shares of the company’s stock in a transaction dated Friday, November 22nd. The stock was sold at an average price of $3.90, for a total transaction of $253,500.00. Following the transaction, the director now owns 972,078 shares in the company, valued at approximately $3,791,104.20. This trade represents a 6.27 % decrease in their position. The disclosure for this sale can be found here. 20.40% of the stock is owned by corporate insiders.
Hyliion Profile
Featured Articles
- Five stocks we like better than Hyliion
- How Investors Can Find the Best Cheap Dividend Stocks
- Dave & Buster’s: Is It Time to Make Another Play on This Stock?
- Best Stocks Under $5.00
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- What is Insider Trading? What You Can Learn from Insider Trading
- Texas Instruments: The Old-School Tech Titan Still Delivering
Want to see what other hedge funds are holding HYLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hyliion Holdings Corp. (NYSE:HYLN – Free Report).
Receive News & Ratings for Hyliion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyliion and related companies with MarketBeat.com's FREE daily email newsletter.